Affluent Medical S.A.
AFME.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$211.22M
Close$
Share Statistics
| Market cap | $211.22 Million |
|---|---|
| Enterprise Value | $230.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.37 |
| Beta | 0.79 |
| Outstanding Shares | 39,348,226 |
Return
| Return on Equity | -102.01% |
|---|---|
| Return on Assets | -44.36% |
| Return on Invested Capital | -58.27% |
Valuation & Multiples
| P/E Ratio | -8.28 |
|---|---|
| PEG | -17.2 |
| Price to Sales | - |
| Price to Book Ratio | 2.81 |
| Enterprise Value to Revenue | 49.02 |
| Enterprise Value to EBIT | -5.76 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Carvolix S.A.
104 employees
CEO: Sebastien Ladet Carvolix S.A. operates as a medical technology firm, concurrently involved in both commercialization and clinical development, specializing in treatment solutions for structural heart ailments and cerebral strokes. The company's innovati...